Immuneering Corporation (IMRX) Stock Grade

About Immuneering Corporation's fundamentals

Immuneering Corporation is a biotechnology company with a market capitalization of $151.0 million that reported flat revenue growth year-over-year at 0.0%, indicating no expansion in sales during the latest period. The company generated a net loss in its latest annual statement, resulting in a net margin of 0.0%, and does not currently pay dividends to shareholders. Traditional valuation metrics like P/E ratio and return on equity are not applicable due to the company's unprofitable status.